A Pan-detecting Assay Based on Stool Samples for Taiwanese Population
Background and objective: Fecal occult blood test (FOBT) is a convenient tool for the
screening of asymptomatic gastrointestinal (GI) bleeding while 「guaiac-based fecal occult
test (G-FOBT) 」 is increasingly replaced by the use of an 「immunochemical-based test
(I-FOBT) 」 that reacts with human globin, a protein that is digested by upper GI enzymes and
is specific for detecting lower GI bleeding. However, in Taiwan, although the incidence of
colorectal cancer is rapidly increasing, Helicobacter pylori-related upper GI pathologies
remain highly prevalent, which may imply that mass screening solely based on I-FOBT could be
insufficient as significant upper GI pathologies can be missed. Since I-FOBT dose not
predict upper GI pathologies, the adjuncts of G-FOBT and H. pylori stool-antigen test (HpSA)
may be a potential candidate to realize a pan-detecting assay based on stool samples in a
population in which both lower and upper GI lesions are equally prevalent.
Patients: Our study will enroll consecutive subjects participating in the health check-up at
National Taiwan University Hospital (Health Management Center), who will undergo I-FOBT,
G-FOBT, HpSA, colonoscopy and EGD. The diagnostic values of three fecal testing, alone or in
combination, will be respectively evaluated. knowing that subjects who were detected with
gastrointestinal tract cancers might be small based on one screening setting, we also
recruited patients who were detected with gastrointestinal tract cancers at other screening
sites and were referred to the National Taiwan University Hospital for confirmatory
diagnosis and treatment. They were also requested to complete the three fecal tests as well
as the bidirectional endoscopies; however, it should be noted that, in this group of
patients, those who completed only one of the bidirectional endoscopies were still eligible.
Our primary hypothesis was to test whether a guaiac-based test combined with an
immunochemical test could help differentiate occult bleeding in the upper gastrointestinal
tract from that in the lower gastrointestinal tract. As such a hypothesis would not be held,
we also evaluated an alternative choice based on Helicobacter pylori stool antigen test to
catching the upper gastrointestinal tract lesions.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Important Lower and Upper GI tract Lesions
We define significant lower GI lesions as mass lesions (carcinoma and advanced adenoma), inflammation (erosive esophagitis, ulcer, and colitis), and vascular disorders (vascular ectasia and varices). Hyperplastic polyps are not considered significant lesions. Important upper GI lesions include cancer, esophageal varix, ulcer at least 0.5 cm in diameter with a perceptible depth, and angiodysplasia. Biopsies will be performed over any suspicious lesions for pathological confirmation. Reflux esophagitis with Los Angeles grade A or B severity is not considered significant.
On the day of receving endoscopy
No
Yi-Chia Lee, MD.PhD
Principal Investigator
National Taiwan University Hospital
Taiwan: Department of Health
201101016RC
NCT01341197
March 2011
November 2012
Name | Location |
---|